Satoshi Miyata Selected Research

Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))

1/2021	Identification of Celastrol as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension and Right Ventricular Failure Through Suppression of Bsg (Basigin)/CyPA (Cyclophilin A).
4/2016	Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
9/2014	Basigin mediates pulmonary hypertension by promoting inflammation and vascular smooth muscle cell proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoshi Miyata Research Topics

Disease

28	Heart Failure 02/2024 - 01/2013
15	Pulmonary Hypertension 12/2023 - 01/2014
14	Neoplasms (Cancer) 01/2023 - 06/2002
12	Myocardial Infarction 01/2022 - 01/2014
11	Inflammation (Inflammations) 01/2022 - 01/2009
10	Spasm (Spasms) 01/2022 - 01/2014
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2013
9	Hypoxia (Hypoxemia) 01/2021 - 01/2016
5	Pathologic Constriction (Stenosis) 03/2024 - 03/2019
5	Atrial Fibrillation 01/2022 - 01/2019
5	Pulmonary Arterial Hypertension 01/2021 - 01/2018
4	Hypertension (High Blood Pressure) 01/2022 - 07/2013
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2017
4	Diabetes Complications 05/2021 - 06/2003
4	Hypertrophy 01/2021 - 01/2014
4	Fibrosis (Cirrhosis) 01/2021 - 01/2014
4	Myocardial Ischemia (Ischemic Heart Diseases) 12/2019 - 01/2015
4	Diabetic Nephropathies (Diabetic Nephropathy) 05/2008 - 03/2003
3	Infections 02/2024 - 01/2015
3	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2007
3	Death (Near-Death Experience) 01/2022 - 01/2019
3	Shock 01/2022 - 01/2014
3	Unstable Angina 01/2022 - 08/2020
3	Cognitive Dysfunction 04/2020 - 01/2017
3	Anemia 01/2019 - 01/2015
3	Stomach Neoplasms (Stomach Cancer) 10/2009 - 09/2008
2	Heart Diseases (Heart Disease) 12/2023 - 01/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 09/2022 - 01/2018
2	Hemorrhage 01/2022 - 01/2020
2	Thrombosis (Thrombus) 01/2022 - 04/2017
2	Dyslipidemias (Dyslipidemia) 01/2022 - 08/2020
2	Stroke (Strokes) 01/2022 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 12/2012
2	Lung Neoplasms (Lung Cancer) 08/2021 - 12/2012
2	Coronary Stenosis (Coronary Artery Stenosis) 01/2021 - 03/2019
2	Dementia (Dementias) 01/2021 - 09/2018
2	Diabetes Mellitus 01/2020 - 01/2015
2	Neoplasm Metastasis (Metastasis) 11/2015 - 11/2009
2	Sudden Death 10/2015 - 01/2015
2	Fibrosarcoma 11/2009 - 06/2002
2	Proteinuria 05/2008 - 06/2003
2	Diabetic Neuropathies (Diabetic Neuropathy) 06/2005 - 07/2004
1	Delirium 12/2023

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2007
8	rho-Associated KinasesIBA 12/2019 - 01/2014
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2015
6	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2021 - 01/2014
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2009
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 01/2014
5	Angiotensin Receptor AntagonistsIBA 01/2022 - 07/2013
4	NitratesIBA 08/2020 - 01/2014
4	olmesartanIBA 01/2019 - 07/2013
4	Complementary DNA (cDNA)IBA 11/2008 - 06/2002
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 04/2015
3	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2021 - 09/2014
3	Cyclophilin AIBA 01/2021 - 01/2017
3	C-Reactive ProteinIBA 10/2019 - 01/2017
3	omega-Chloroacetophenone (Mace)IBA 01/2019 - 09/2013
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022 - 08/2020
2	AnticoagulantsIBA 01/2022 - 01/2020
2	Phenobarbital (Luminal)FDA Link 01/2021 - 03/2019
2	CytokinesIBA 01/2021 - 01/2019
2	MonocrotalineIBA 01/2021 - 01/2014
2	CreatinineIBA 01/2021 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 01/2019
2	fasudil (AT 877)IBA 12/2019 - 01/2014
2	Selenoprotein PIBA 12/2019 - 01/2018
2	pro-brain natriuretic peptide (1-76)IBA 01/2019 - 01/2019
2	AlbuminsIBA 01/2019 - 01/2009
2	GTP-Binding Proteins (G-Protein)IBA 11/2018 - 03/2008
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2018 - 01/2016
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 01/2017
2	Glutathione (Reduced Glutathione)IBA 01/2018 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 11/2009
2	EnzymesIBA 01/2016 - 08/2009
2	Serum AlbuminIBA 01/2015 - 01/2013
2	Messenger RNA (mRNA)IBA 12/2012 - 10/2009
2	Fatty Acids (Saturated Fatty Acids)IBA 08/2009 - 01/2009
2	Streptozocin (Streptozotocin)FDA Link 05/2008 - 06/2007
2	AntioxidantsIBA 05/2008 - 06/2007
2	p38 Mitogen-Activated Protein KinasesIBA 07/2004 - 03/2003
1	Triamcinolone (Aristocort)FDA Link 03/2024
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 03/2024
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 12/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2023
1	Soluble Guanylyl CyclaseIBA 12/2023

Therapy/Procedure

20	Therapeutics 12/2023 - 01/2007
5	Percutaneous Coronary Intervention 01/2021 - 01/2015
4	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 01/2015
3	Renal Dialysis (Hemodialysis) 10/2022 - 01/2014
3	Gastrectomy 04/2009 - 09/2008
2	Cardiac Resynchronization Therapy 02/2024 - 06/2022
2	Transcatheter Aortic Valve Replacement 12/2023 - 04/2020
2	Stents 12/2019 - 09/2016
2	Patient Readmission 12/2019 - 01/2017
2	Drug-Eluting Stents 01/2019 - 01/2017
2	Lasers (Laser) 11/2008 - 12/2007
1	Colonoscopes 03/2024
1	Personal Protective Equipment 02/2024
1	Polypharmacy 02/2024